GM and KM allotypes-genetic markers of immunoglobulin (Ig) ␥ and chains, respectively-are associated with humoral immunity to several infection-and autoimmunity-related epitopes. We hypothesized that GM and KM allotypes contribute to the generation of autoantibodies to liver/kidney microsomal antigen 1 (LKM1) in hepatitis C virus (HCV)-infected persons. To test this hypothesis, we characterized 129 persons with persistent HCV infection for several GM and KM markers and for anti-LKM1 antibodies. The heterozygous GM 1,3,17 23 5,13,21 phenotype was significantly associated with the prevalence of anti-LKM1 antibodies (odds ratio, 5.13; P ؍ 0.002), suggesting its involvement in this autoimmune phenomenon in HCV infection.Autoantibodies to LKM1 are present in 1 to 10% of patients with hepatitis C virus (HCV)-related chronic hepatitis (3,4,11,21). The presence of these autoantibodies is associated with an increased risk of developing hepatitic flares and thyroid disorders in HCV-infected patients (17, 18). The antigenic target of anti-LKM1 antibodies is cytochrome P450IID6 (CYPIID6), a 50-kDa microsomal enzyme involved in the metabolism of xenobiotics (12,19,41). Molecular mimicry between HCV proteins and CYPIID6 has been suggested as a possible mechanism for the origin of these autoantibodies (2, 13). Certain HLA and CYPIID6 alleles are associated with the prevalence of LKM1 autoantibodies in some populations, suggesting the involvement of host genetic factors in the induction of these antibodies (2, 9).Immunoglobulin (Ig) GM and KM allotypes-hereditary antigenic determinants of IgG heavy chains and -type light chains, respectively-are associated with susceptibility to several autoimmune and infectious diseases (7,8,24,27,30,31,34). They also influence immune responsiveness to infectious epitopes as well as to certain autoantigens (10,25,26,28,29). Of particular relevance here, certain GM and KM determinants interact to influence the outcome of HCV infection (22). These observations led us to hypothesize that GM and KM allotypes may contribute to the generation of anti-LKM1 autoantibodies in HCV-infected subjects.Between 2002 and 2004, 129 HCV-infected patients were consecutively enrolled at the Department of Internal Medicine, Cardioangiology, and Hepatology, Alma Mater Studiorum-University of Bologna. Criteria for inclusion in the study were the following: serum anti-HCV and HCV RNA positivity, abnormal alanine transaminase levels at least twice in the past 6 months, and chronic inflammation on liver histology. Other causes of liver disease were excluded by appropriate tests. The study population also included 90 ethnically matched blood donors who were negative for anti-HCV antibodies. The study was approved by the appropriate ethics committees for human research.Anti-HCV antibodies were tested by third-generation enzyme immunoassay (Ortho HCV version 3.0 ELISA; OrthoClinical Diagnostics, Inc., Raritan, NJ) according to the manufacturer's instructions, and HCV RNA was tested by nested PCR using primers derived fr...